Claim Missing Document
Check
Articles

Found 2 Documents
Search

Clinical Characteristics of COVID-19 Pneumonia Patients in Abdoel Moeloek Regional Public Hospital, Bandar Lampung, Indonesia. Soemarwoto, Retno AS; Marlina, Nina; Mustafa, Syazili; Sukarti, Sukarti; Sinaga, Fransisca; Gozali, Ahmad; Hapsari, Tantri Dwi KR; Hidayat, Hidayat
Jurnal Kedokteran Universitas Lampung Vol 4, No 1 (2020): JK UNILA
Publisher : Fakultas Kedokteran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.23960/jk unila.v4i1.2761

Abstract

a novel coronavirus (SARS-CoV-2) causes a new, really infectious viral disease named COVID-19. This infection quickly develops into a pandemic and it is becoming a major problem in the world. Pneumonia is a severe and dangerous complication of the disease. In this study, we aimed at exploring the clinical characteristics of the COVID-19 pneumonia. A retrospective single-center study in Abdoel Moeloek Hospital of Lampung Province was conducted on March to May 2020. It enrolled 12 Hospitalized patients with confirmed COVID-19 pneumonia by real-time RT-PCR. The purpose of this study was to investigate and describe the features of this epidemic disease. The clinical features, laboratory findings and chest X-ray images of them were reviewed and analyzed. Consecutive patients with COVID-19 pneumonia were included in the study. There were 7 patients who recovered while 5 of them died. Most of them were male (10 patients or 83%) and they were about 40 years (9 patients or 75%). Most of patients (75%) had comorbid disease such as hypertension, diabetes, hepatitis, obesity, and heart disease and they also had a history of travel from infected area. They who died (5 patients or 100%) had comorbid diseases. The patients main complaints were cough and shortness of breath (12 patients or 100%), subfebrile fever (9 patients or 75%), diarrhea (5 patients or 42%), abdominal pain nausea and vomiting (4 patients or 33%). Related to laboratory examination, they got decreasing of calcium level (11 patient or 91%), lymphocytes (9 patients or 75%), hemoglobin level (8 patients or 67%) and albumin levels (7 patients or 58%). On the contrary, they got increasing of the level of the erythrocyte sedimentation rates (12 patients or 100%), the level of C-reactive protein (11 patients or 91%), physiological coagulation (12 patients or 100%), D-dimers plasma levels (10 patients or 83%), liver enzymes test (9 patients or 75%), leukocytes (7 patients or 57%), and chloride (6 patients or 50%). In the chest X-ray interpretations, we found that most of cases ( 10 patients or 83%) were bilateral pneumonia and they occurred massively in the inferior lobe of the lung. On the death cases, they were found consolidation in both lower lung fields. The clinical data, laboratory and radiological examination of patients with COVID-19 pneumonia showed both inflammation and coagulopathy. A decreased lymphocyte count and plasma calcium level, and an increased high-sensitivity C-reactive protein level and D-dimer plasma level were the most common laboratory findings. The infection caused severe acute respiratory syndrome and it was correlated to high mortality. High efforts are needed for further studies to fulfill the gap in knowledge of this disease.Key words: COVID-19 pneumonia, clinical manifestation, laboratory findings, chest X-ray, SARS-CoV-2,
Anak dengan Tuberkulosis (TB) Paru Kasus Baru Terkonfirmasi Bakteriologis dengan Riwayat Human Immunodeficiency Virus (HIV) yang Menjalani Pengobatan Antiretroviral (ARV) Soemarwoto, Retno Ariza S; Afryan, I Made; Nareswari, Shinta; Sinaga, Fransisca; Saputra, Oktadoni; Herliyana, Lina; Hidayat, Hidayat
Medula Vol 14 No 10 (2025): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v14i10.1423

Abstract

Tuberculosis (TB) in children with Human Immunodeficiency Virus (HIV) is a complex clinical challenge due to the synergistic interaction between these two diseases, which mutually worsen the patient's clinical condition. HIV decreases immunity, thus increasing the risk of TB infection, while TB accelerates HIV progressivity. TB-HIV co-infection is a major cause of morbidity and mortality, especially in children with undetected M. Tuberculosis infection. By 2022, an estimated 710,000 HIV patients will develop TB, of which 187,000 will die. This article aims to provide an update on the management of pulmonary TB in children with HIV who are routinely on antiretroviral (ARV) treatment. The discussion covers the definition, epidemiology, etiology, disease progression, pathogenesis, diagnosis, supporting investigations, and management of TB-HIV. The diagnosis of TB in children with HIV is often difficult due to non-specific clinical manifestations and limitations of diagnostic tests. Therefore, early detection through comprehensive testing is essential. TB-HIV management requires a multidisciplinary approach, including appropriate TB treatment and integrated ARV administration. Intensive monitoring is also required to prevent complications, such as drug resistance or adverse effects of therapy. In conclusion, this article emphasizes the importance of a holistic approach in evaluating and managing pulmonary TB in children with HIV, including interprofessional collaboration, family education, and preventive efforts to improve patients' quality of life and reduce mortality.